S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
New AI Stock Payouts (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
New AI Stock Payouts (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
New AI Stock Payouts (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
New AI Stock Payouts (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
NASDAQ:ALVOW

Alvotech (ALVOW) Competitors

$1.68
+0.20 (+13.51%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.68
$1.68
50-Day Range
$1.31
$1.91
52-Week Range
$0.37
$3.11
Volume
2,047 shs
Average Volume
39,729 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ALVOW vs. SXTPW, ACONW, AIMDW, DRTSW, ALVO, APGNW, APLMW, APTX, ABIO, and BIAFW

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVO), Apexigen (APGNW), Apollomics (APLMW), Aptinyx (APTX), ARCA biopharma (ABIO), and bioAffinity Technologies (BIAFW). These companies are all part of the "medical" sector.

Alvotech vs.

60 Degrees Pharmaceuticals, Inc. Warrant (NASDAQ:SXTPW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment, institutional ownership and community ranking.

60 Degrees Pharmaceuticals, Inc. Warrant and Alvotech both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
60 Degrees Pharmaceuticals, Inc. WarrantN/AN/A
AlvotechN/AN/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals, Inc. Warrant'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals, Inc. Warrant Neutral
Alvotech Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
60 Degrees Pharmaceuticals, Inc. Warrant
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Alvotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
60 Degrees Pharmaceuticals, Inc. WarrantN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals, Inc. Warrant$207.72KN/AN/AN/AN/A
Alvotech$63.17MN/AN/AN/AN/A

Summary

Alvotech beats 60 Degrees Pharmaceuticals, Inc. Warrant on 1 of the 1 factors compared between the two stocks.


Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVOW vs. The Competition

MetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$170.51M$4.49B$6.28B
Dividend YieldN/AN/A2.52%9.75%
P/E RatioN/A5.12101.7211.13
Price / SalesN/A34.562,853.1463.64
Price / CashN/A16.0495.20101.49
Price / BookN/A6.293.764.83
Net IncomeN/A-$606.60M$122.43M$186.05M
7 Day Performance4.35%-2.44%-2.61%-3.10%
1 Month Performance-6.67%7.81%-2.05%-4.14%
1 Year PerformanceN/A5.20%9.66%5.52%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTPW
60 Degrees Pharmaceuticals, Inc. Warrant
0 of 5 stars
$0.29
-3.3%
N/AN/A$0.00$207,715.000.002Gap Down
ACONW
Aclarion
0 of 5 stars
$0.14
flat
N/AN/A$0.00$83,284.000.00N/ANews Coverage
AIMDW
Ainos
0 of 5 stars
$0.13
flat
N/A-52.3%$0.00$2.87M0.00N/AGap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.27
-3.6%
N/AN/A$0.00N/A0.00N/A
ALVO
Alvotech
0.7622 of 5 stars
$9.14
+0.6%
$8.00
-12.5%
+30.0%$0.00$85.02M0.00917Analyst Report
Gap Up
APGNW
Apexigen
0 of 5 stars
$0.03
+30.5%
N/A-85.3%$0.00N/A0.00N/A
APLMW
Apollomics
0 of 5 stars
$0.06
flat
N/AN/A$0.00N/A0.0059Positive News
Gap Down
APTX
Aptinyx
0 of 5 stars
$0.07
flat
$0.50
+603.2%
-83.6%$0.00$1M-0.0712
ABIO
ARCA biopharma
0 of 5 stars
$2.06
flat
N/A-5.6%$0.00N/A-4.795Short Interest ↓
BIAFW
bioAffinity Technologies
0 of 5 stars
$0.21
flat
N/A-83.3%$0.00$24,156.000.00N/ANews Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:ALVOW) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -